COVID-19 Testing and Vaccination Among Spanish Speakers
NCT ID: NCT05302908
Last Updated: 2026-01-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
274 participants
INTERVENTIONAL
2023-02-09
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Public Health Interventions to Improve COVID-19 Testing Among Underserved Populations
NCT05270694
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NCT06128928
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
NCT05123729
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
NCT04731870
Equitable Access to COVID-19 Vaccines
NCT04952376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NuestraSaludSegura intervention
Intervention-group Navegantes will be trained and supported for 6 months of implementation in Years 1-2
NuestraSaludSegura
It blends peer navigation and mHealth
delayed NuestraSaludSegura intervention
delayed-intervention group Navegantes will be trained in Year 2
NuestraSaludSegura
It blends peer navigation and mHealth
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NuestraSaludSegura
It blends peer navigation and mHealth
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* participant must be Spanish speaking
* participant reports having been vaccinated against COVID-19
* participant must be ≥18 years of age
* participant must provide informed consent
* participant must self-identify as Hispanic/Latinx
* participant must be Spanish speaking
* participant must be ≥ 18 years of age
* participant must provide informed consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott D Rhodes, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rhodes SD, Tanner AE, Mann-Jackson L, Alonzo J, Hall MA, Bertoni AG, McCoy TP, Aguilar-Palma SK, Garcia M, Miranda D, Turner MJ. Increasing COVID-19 testing and vaccination among Spanish speakers in the USA: protocol for the development and evaluation of the Nuestra Comunidad Saludable intervention using a group-randomised trial design. BMJ Open. 2022 Nov 16;12(11):e066585. doi: 10.1136/bmjopen-2022-066585.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00079510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.